UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 866

Sortiert nach

Dopamine in Health and Disease: Much More Than a Neurotransmitter

Biomedicines, 2021-01, Vol.9 (2), p.109

2021

Volltextzugriff (PDF)

Adenosine A2A Receptor Antagonists in Neurodegenerative Diseases: Huge Potential and Huge Challenges

Frontiers in psychiatry, 2018-03, Vol.9, p.68-68

2018

Volltextzugriff (PDF)

Neuroprotection afforded by targeting G protein-coupled receptors in heteromers and by heteromer-selective drugs

Frontiers in pharmacology, 2023-07, Vol.14, p.1222158-1222158

2023

Volltextzugriff (PDF)

Melatonin and the control of intraocular pressure

Progress in retinal and eye research, 2020-03, Vol.75, p.100798-100798, Article 100798

2020

Volltextzugriff (PDF)

Evidence for functional pre-coupled complexes of receptor heteromers and adenylyl cyclase

Nature communications, 2018-03, Vol.9 (1), p.1242-12, Article 1242

2018

Volltextzugriff (PDF)

Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors

PLoS biology, 2015-07, Vol.13 (7), p.e1002194-e1002194

2015

Volltextzugriff (PDF)

Basic Pharmacological and Structural Evidence for Class A G-Protein-Coupled Receptor Heteromerization

Frontiers in pharmacology, 2016-03, Vol.7, p.76-76

2016

Volltextzugriff (PDF)

Binding and Signaling Studies Disclose a Potential Allosteric Site for Cannabidiol in Cannabinoid CB2 Receptors

Frontiers in pharmacology, 2017-10, Vol.8, p.744-744

2017

Volltextzugriff (PDF)

Activated and non-activated PAMAM dendrimers for gene delivery in vitro and in vivo

Nanomedicine, 2009-09, Vol.5 (3), p.287-297

2009

Volltextzugriff (PDF)

Cross-communication between Gi and Gs in a G-protein-coupled receptor heterotetramer guided by a receptor C-terminal domain

BMC biology, 2018-02, Vol.16 (1), p.24-24, Article 24

2018

Volltextzugriff (PDF)

The Expression and Functionality of CB1R-NMDAR Complexes Are Decreased in A Parkinson’s Disease Model

International journal of molecular sciences, 2024-03, Vol.25 (5), p.3021

2024

Volltextzugriff (PDF)

Allosteric mechanisms within the adenosine A2A–dopamine D2 receptor heterotetramer

Neuropharmacology, 2016-05, Vol.104, p.154-160

2016

Volltextzugriff (PDF)

Cocaine inhibits dopamine D2 receptor signaling via sigma-1-D2 receptor heteromers

PloS one, 2013-04, Vol.8 (4), p.e61245

2013

Volltextzugriff (PDF)

Cannabigerol Action at Cannabinoid CB1 and CB2 Receptors and at CB1–CB2 Heteroreceptor Complexes

Frontiers in pharmacology, 2018-06, Vol.9, p.632-632

2018

Volltextzugriff (PDF)

Antioxidants versus Food Antioxidant Additives and Food Preservatives

Antioxidants, 2019-11, Vol.8 (11), p.542

2019

Volltextzugriff (PDF)

Purinergic signaling in Parkinson's disease. Relevance for treatment

Neuropharmacology, 2016-05, Vol.104, p.161-168

2016

Volltextzugriff (PDF)

Genes Implicated in Familial Parkinson's Disease Provide a Dual Picture of Nigral Dopaminergic Neurodegeneration with Mitochondria Taking Center Stage

International journal of molecular sciences, 2021-04, Vol.22 (9), p.4643

2021

Volltextzugriff (PDF)

Antioxidant Defense Mechanisms in Erythrocytes and in the Central Nervous System

Antioxidants, 2019-02, Vol.8 (2), p.46

2019

Volltextzugriff (PDF)

Understanding the Role of Adenosine A2AR Heteroreceptor Complexes in Neurodegeneration and Neuroinflammation

Frontiers in neuroscience, 2018-02, Vol.12, p.43-43

2018

Volltextzugriff (PDF)

Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Role of CB1 and CB2 receptors and relevance for Alzheimer’s disease and levodopa-induced dyskinesia

Brain, behavior, and immunity, 2018-01, Vol.67, p.139-151

2018

Volltextzugriff (PDF)

A Robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery

Molecules (Basel, Switzerland), 2023-12, Vol.28 (24), p.8107

2023

Volltextzugriff (PDF)

Cannabinoid and Orexigenic Systems Interplay as a New Focus of Research in Alzheimer's Disease

International journal of molecular sciences, 2024-05, Vol.25 (10), p.5378

2024

Volltextzugriff (PDF)

Adenosine Receptor Antagonists to Combat Cancer and to Boost Anti-Cancer Chemotherapy and Immunotherapy

Cells (Basel, Switzerland), 2021-10, Vol.10 (11), p.2831

2021

Volltextzugriff (PDF)

Hormetic and Mitochondria-Related Mechanisms of Antioxidant Action of Phytochemicals

Antioxidants, 2019-09, Vol.8 (9), p.373

2019

Volltextzugriff (PDF)

1 – 25 von 866

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(808)
Mit Volltextzugriff
(809)

Publikationsform

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(13)

Menü

Weitere Dienste

Einstellungen

Dopamine in Health and Disease: Much More Than a Neurotransmitter

Adenosine A2A Receptor Antagonists in Neurodegenerative Diseases: Huge Potential and Huge Challenges

Neuroprotection afforded by targeting G protein-coupled receptors in heteromers and by heteromer-selective drugs

Melatonin and the control of intraocular pressure

Evidence for functional pre-coupled complexes of receptor heteromers and adenylyl cyclase

Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors

Basic Pharmacological and Structural Evidence for Class A G-Protein-Coupled Receptor Heteromerization

Binding and Signaling Studies Disclose a Potential Allosteric Site for Cannabidiol in Cannabinoid CB2 Receptors

Activated and non-activated PAMAM dendrimers for gene delivery in vitro and in vivo

Cross-communication between Gi and Gs in a G-protein-coupled receptor heterotetramer guided by a receptor C-terminal domain

The Expression and Functionality of CB1R-NMDAR Complexes Are Decreased in A Parkinson’s Disease Model

Allosteric mechanisms within the adenosine A2A–dopamine D2 receptor heterotetramer

Adenosine/A2B Receptor Signaling Ameliorates the Effects of Aging and Counteracts Obesity

Cocaine inhibits dopamine D2 receptor signaling via sigma-1-D2 receptor heteromers

Cannabigerol Action at Cannabinoid CB1 and CB2 Receptors and at CB1–CB2 Heteroreceptor Complexes

Antioxidants versus Food Antioxidant Additives and Food Preservatives

Purinergic signaling in Parkinson's disease. Relevance for treatment

Genes Implicated in Familial Parkinson's Disease Provide a Dual Picture of Nigral Dopaminergic Neurodegeneration with Mitochondria Taking Center Stage

Antioxidant Defense Mechanisms in Erythrocytes and in the Central Nervous System

Understanding the Role of Adenosine A2AR Heteroreceptor Complexes in Neurodegeneration and Neuroinflammation

Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Role of CB1 and CB2 receptors and relevance for Alzheimer’s disease and levodopa-induced dyskinesia

A Robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery

Cannabinoid and Orexigenic Systems Interplay as a New Focus of Research in Alzheimer's Disease

Adenosine Receptor Antagonists to Combat Cancer and to Boost Anti-Cancer Chemotherapy and Immunotherapy

Hormetic and Mitochondria-Related Mechanisms of Antioxidant Action of Phytochemicals

Suchergebnisse filtern